DK2983685T3 - Sammensætning, omfattende en forbindelse af et hyldudtræk og en stamme af Lactobacillus rhamnosus - Google Patents

Sammensætning, omfattende en forbindelse af et hyldudtræk og en stamme af Lactobacillus rhamnosus Download PDF

Info

Publication number
DK2983685T3
DK2983685T3 DK14718542.5T DK14718542T DK2983685T3 DK 2983685 T3 DK2983685 T3 DK 2983685T3 DK 14718542 T DK14718542 T DK 14718542T DK 2983685 T3 DK2983685 T3 DK 2983685T3
Authority
DK
Denmark
Prior art keywords
elder
extract
composition
lactobacillus rhamnosus
probiotic
Prior art date
Application number
DK14718542.5T
Other languages
English (en)
Inventor
Christian Jacques Latge
Christine Libon
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of DK2983685T3 publication Critical patent/DK2983685T3/da

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B1/00—Layered products having a non-planar shape
    • B32B1/08—Tubular products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B15/00—Layered products comprising a layer of metal
    • B32B15/04—Layered products comprising a layer of metal comprising metal as the main or only constituent of a layer, which is next to another layer of the same or of a different material
    • B32B15/08—Layered products comprising a layer of metal comprising metal as the main or only constituent of a layer, which is next to another layer of the same or of a different material of synthetic resin
    • B32B15/088—Layered products comprising a layer of metal comprising metal as the main or only constituent of a layer, which is next to another layer of the same or of a different material of synthetic resin comprising polyamides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B15/00—Layered products comprising a layer of metal
    • B32B15/20—Layered products comprising a layer of metal comprising aluminium or copper
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00—Layered products comprising a layer of synthetic resin
    • B32B27/34—Layered products comprising a layer of synthetic resin comprising polyamides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B60—VEHICLES IN GENERAL
    • B60R—VEHICLES, VEHICLE FITTINGS, OR VEHICLE PARTS, NOT OTHERWISE PROVIDED FOR
    • B60R16/00—Electric or fluid circuits specially adapted for vehicles and not otherwise provided for; Arrangement of elements of electric or fluid circuits specially adapted for vehicles and not otherwise provided for
    • B60R16/08—Electric or fluid circuits specially adapted for vehicles and not otherwise provided for; Arrangement of elements of electric or fluid circuits specially adapted for vehicles and not otherwise provided for fluid
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B62—LAND VEHICLES FOR TRAVELLING OTHERWISE THAN ON RAILS
    • B62D—MOTOR VEHICLES; TRAILERS
    • B62D29/00—Superstructures, understructures, or sub-units thereof, characterised by the material thereof
    • B62D29/04—Superstructures, understructures, or sub-units thereof, characterised by the material thereof predominantly of synthetic material
    • B62D29/043—Superstructures
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/16—Nitrogen-containing compounds
    • C08K5/34—Heterocyclic compounds having nitrogen in the ring
    • C08K5/3412—Heterocyclic compounds having nitrogen in the ring having one nitrogen atom in the ring
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/16—Nitrogen-containing compounds
    • C08K5/34—Heterocyclic compounds having nitrogen in the ring
    • C08K5/35—Heterocyclic compounds having nitrogen in the ring having also oxygen in the ring
    • C08K5/353—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L77/00—Compositions of polyamides obtained by reactions forming a carboxylic amide link in the main chain; Compositions of derivatives of such polymers
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L11/00—Hoses, i.e. flexible pipes
    • F16L11/04—Hoses, i.e. flexible pipes made of rubber or flexible plastics
    • F16L11/045—Hoses, i.e. flexible pipes made of rubber or flexible plastics with four or more layers without reinforcement
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L11/00—Hoses, i.e. flexible pipes
    • F16L11/04—Hoses, i.e. flexible pipes made of rubber or flexible plastics
    • F16L11/08—Hoses, i.e. flexible pipes made of rubber or flexible plastics with reinforcements embedded in the wall
    • F16L11/085—Hoses, i.e. flexible pipes made of rubber or flexible plastics with reinforcements embedded in the wall comprising one or more braided layers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2307/00—Properties of the layers or laminate
    • B32B2307/50—Properties of the layers or laminate having particular mechanical properties
    • B32B2307/54—Yield strength; Tensile strength
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2377/00—Polyamides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B32—LAYERED PRODUCTS
    • B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2597/00—Tubular articles, e.g. hoses, pipes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mechanical Engineering (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Transportation (AREA)
  • Combustion & Propulsion (AREA)
  • Structural Engineering (AREA)
  • Architecture (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Claims (7)

1. Sammensætning, omfattende en synergisk forbindelse af et hyldudtræk og mindst én stamme af Lactobacillus rhamnosus, hvor hyldudtrækket omfatter et indhold af anthocyaner, som ligger mellem 0,5 og 25 vægt% i forhold til tørstoffet af udtrækket, og et indhold af proteiner, som ligger mellem 2 og 10 vægt% i forhold til tørstoffet af udtrækket, til anvendelse deraf til at stimulere immuniteten og/eller forstærke immunforsvaret.
2. Sammensætning, omfattende en synergisk forbindelse af et hyldudtræk og mindst én stamme af Lactobacillus rhamnosus, hvor hyldudtrækket omfatter et indhold af anthocyaner, som ligger mellem 0,5 og 25 vægt% i forhold til tørstoffet af udtrækket, og et indhold af proteiner, som ligger mellem 2 og 10 vægt% i forhold til tørstoffet af udtrækket, til anvendelse deraf i behandlingen og/eller forebyggelsen af symptomerne på influenzalignende tilstande.
3. Sammensætning til anvendelse deraf ifølge et af kravene 1 eller 2, kendetegnet ved, at den omfatter en kvantitet af Lactobacillus rhamnosus, som ligger mellem 1.107 og 1.1011 UFC/enhedsdosis.
4. Sammensætning til anvendelse deraf ifølge et hvilket som helst af kravene 1 til 3, kendetegnet ved, at det drejer sig om et kosttilskud eller et lægemiddel.
5. Sammensætning til anvendelse deraf ifølge et hvilket som helst af kravene 1 til 4, kendetegnet ved, at det drejer sig om et kosttilskud i galenisk form, der er udvalgt fra gruppen bestående af kapsler, tabletter til at sluge, tyggetabletter, brusetabletter, pastiller, pulvere, små korn, opløsninger eller orale suspensioner og former til sublingual og buccal indgivelse.
6. Sammensætning til anvendelse deraf ifølge et hvilket som helst af kravene 1 til 5, kendetegnet ved, at den omfatter mellem 20 mg og 200 mg tørekstrakt af hyld per enhedsdosis, fortrinsvis mellem 20 mg og 100 mg tørekstrakt af hyld per enhedsdosis, og mellem 1.107 og 1.1011 UFC de Lactobacillus rham-nosus per enhedsdosis, fortrinsvis mellem 1.108 og 1.109 UFC af Lactobacillus rhamnosus per enhedsdosis.
7. Sammensætning til anvendelse deraf ifølge et hvilket som helst af kravene 1 til 6, kendetegnet ved, at den desuden omfatter vitaminer og/eller mineralsalte.
DK14718542.5T 2013-04-09 2014-04-08 Sammensætning, omfattende en forbindelse af et hyldudtræk og en stamme af Lactobacillus rhamnosus DK2983685T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1353193A FR3004109B1 (fr) 2013-04-09 2013-04-09 Composition comprenant une association d'un extrait de sureau et d'une souche de lactobacillus rhamnosus
PCT/EP2014/057082 WO2014166960A1 (fr) 2013-04-09 2014-04-08 Composition comprenant une association d'un extrait de sureau et d'une souche de lactobacillus rhamnosus

Publications (1)

Publication Number Publication Date
DK2983685T3 true DK2983685T3 (da) 2019-03-11

Family

ID=48570385

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14718542.5T DK2983685T3 (da) 2013-04-09 2014-04-08 Sammensætning, omfattende en forbindelse af et hyldudtræk og en stamme af Lactobacillus rhamnosus

Country Status (19)

Country Link
US (1) US20160082055A1 (da)
EP (1) EP2983685B1 (da)
JP (1) JP6660289B2 (da)
KR (1) KR20150139957A (da)
CN (1) CN105228637A (da)
BR (1) BR112015025733A2 (da)
CY (1) CY1121491T1 (da)
DK (1) DK2983685T3 (da)
ES (1) ES2711821T3 (da)
FR (1) FR3004109B1 (da)
HU (1) HUE043671T2 (da)
MX (1) MX365284B (da)
PL (1) PL2983685T3 (da)
PT (1) PT2983685T (da)
RU (1) RU2668126C2 (da)
TN (1) TN2015000442A1 (da)
TR (1) TR201902055T4 (da)
WO (1) WO2014166960A1 (da)
ZA (1) ZA201508222B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3050737B1 (fr) * 2016-04-27 2018-04-06 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Procede d'evaluation de la capacite d'une composition a prevenir la fatigue et les dommages musculaires ; nouveau complement alimentaire et medicament.
KR101938865B1 (ko) * 2016-11-03 2019-01-16 주식회사 쎌바이오텍 골 질환, 비만 및 지질 관련 대사성 질환의 예방 또는 치료용 조성물
GB2562260A (en) * 2017-05-10 2018-11-14 Sis Science In Sport Ltd Compositions
TWI757735B (zh) * 2020-05-06 2022-03-11 葡萄王生技股份有限公司 乳酸菌用於製備抗病毒組合物的用途
CN112841642A (zh) * 2020-12-07 2021-05-28 深圳奥萨制药有限公司 用于抗骨质疏松的组合物
CN112574917B (zh) * 2020-12-16 2022-08-09 无锡特殊食品与营养健康研究院有限公司 一株缓解高尿酸血症的鼠李糖乳杆菌ccfm1131
FR3126869A1 (fr) 2021-09-16 2023-03-17 Gozen K. K. Japan Composition pharmaceutique comprenant des métabolites issus de la bactérie Bacillus subtilis Gozen GZN-08 isolée de Camellia sinensis et modulant la réponse immunitaire.
CN115645327B (zh) * 2022-10-19 2024-03-19 上海瑞帝安生物科技有限公司 一种具有修护作用的西洋接骨木发酵液及其制备工艺和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5019961B2 (ja) * 2006-06-26 2012-09-05 株式会社ヤクルト本社 インターロイキン１０産生促進剤
JP5209294B2 (ja) * 2007-12-25 2013-06-12 株式会社ヤクルト本社 インターロイキン１２産生促進剤
FR2937252B1 (fr) * 2008-10-17 2011-05-20 Pf Medicament Association d'un extrait de sureau et d'une souche de l. paracasei.
SE533778C2 (sv) * 2009-05-14 2011-01-11 Probi Ab Probiotisk fruktdryck

Also Published As

Publication number Publication date
CY1121491T1 (el) 2020-05-29
WO2014166960A1 (fr) 2014-10-16
TR201902055T4 (tr) 2019-03-21
US20160082055A1 (en) 2016-03-24
PT2983685T (pt) 2019-02-27
ES2711821T3 (es) 2019-05-07
HUE043671T2 (hu) 2019-08-28
RU2015147874A (ru) 2017-05-16
KR20150139957A (ko) 2015-12-14
BR112015025733A2 (pt) 2017-07-18
MX2015014266A (es) 2016-03-01
FR3004109A1 (fr) 2014-10-10
JP6660289B2 (ja) 2020-03-11
JP2016516757A (ja) 2016-06-09
MX365284B (es) 2019-05-28
FR3004109B1 (fr) 2016-01-01
RU2668126C2 (ru) 2018-09-26
EP2983685A1 (fr) 2016-02-17
CN105228637A (zh) 2016-01-06
TN2015000442A1 (fr) 2017-01-03
ZA201508222B (en) 2017-01-25
PL2983685T3 (pl) 2019-05-31
EP2983685B1 (fr) 2018-11-21

Similar Documents

Publication Publication Date Title
DK2983685T3 (da) Sammensætning, omfattende en forbindelse af et hyldudtræk og en stamme af Lactobacillus rhamnosus
Gleeson Immunological aspects of sport nutrition
JP5558475B2 (ja) ニワトコ抽出物とｌ．パラカゼイ、ｌ．カゼイ、ｌ．ブルガリクスまたはｓ．サーモフィルスの菌株との組合せを含む組成物
Kumari et al. Potential health benefits of Spirulina platensis
CN111264633A (zh) 一种有益肠道健康的儿童配方奶粉及其制备方法
dos Santos Ferreira et al. Immunonutrition effects on coping with COVID-19
JP2006197911A (ja) 蜂の子利用の健康食品。
WO2021240293A1 (en) Combination of active ingredients, compositions containing it and their use to sustain and strengthen the immune system
Sharoba Spirulina: Functional Compounds And Health Benefits
Dubey et al. Ready to use therapeutic food: a review
US20220305065A1 (en) Health-promoting beverages
WO2022182220A1 (es) Sistema de soporte nutricional para activar las rutas metabólicas alteradas
TWI240631B (en) Peroral medicine for prevention of virus infection
Shahapurkar et al. A REVIEW ON THE NUTRITIONAL VALUE AND POTENTIAL HEALTH BENEFITS OF SPIRULINA
Verma et al. Spirulina spp. in nutritional and clinical practices: a review of applications.
Cohen et al. Single-cell food
Jamison et al. Single-cell food
CN118044620A (zh) 基于植物的组合物及其使用方法
Gupta et al. Nutritional Importance and Value added biochemical of Spirulina
Person Immunity Inside and Out
CZ2015734A3 (cs) Soubor potravinových doplňků a způsob jeho aplikace
Muhamad Effects of nutritional supplements on the immune function of athletes
Oler Immune Health Basics–Beating Cold and Flu Season